110 related articles for article (PubMed ID: 9279366)
21. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
[TBL] [Abstract][Full Text] [Related]
22. Intragenic mutations of the p16(INK4), p15(INK4B) and p18 genes in primary non-small-cell lung cancers.
Rusin MR; Okamoto A; Chorazy M; Czyzewski K; Harasim J; Spillare EA; Hagiwara K; Hussain SP; Xiong Y; Demetrick DJ; Harris CC
Int J Cancer; 1996 Mar; 65(6):734-9. PubMed ID: 8631583
[TBL] [Abstract][Full Text] [Related]
23. The prognostic significance of p16INK4a/p14ARF and p15INK4b deletions in adult acute lymphoblastic leukemia.
Faderl S; Kantarjian HM; Manshouri T; Chan CY; Pierce S; Hays KJ; Cortes J; Thomas D; Estrov Z; Albitar M
Clin Cancer Res; 1999 Jul; 5(7):1855-61. PubMed ID: 10430092
[TBL] [Abstract][Full Text] [Related]
24. The incidence of chromosome 9p21 abnormalities and deletions of tumor suppressor genes p15(INK4b)/p16(INK4a)/p14(ARF) in patients with acute lymphoblastic leukemia.
Faderl S; Estrov Z; Kantarjian HM; Thomas D; Cortes J; Manshouri T; Chan CC; Hays KJ; Pierce S; Albitar M
Cytokines Cell Mol Ther; 1999 Sep; 5(3):159-63. PubMed ID: 10641574
[TBL] [Abstract][Full Text] [Related]
25. In vitro sensitivity of T-cell lymphoblastic leukemia to UCN-01 (7-hydroxystaurosporine) is dependent on p16 protein status: a Pediatric Oncology Group study.
Omura-Minamisawa M; Diccianni MB; Batova A; Chang RC; Bridgeman LJ; Yu J; de Wit E; Kung FH; Pullen JD; Yu AL
Cancer Res; 2000 Dec; 60(23):6573-6. PubMed ID: 11118035
[TBL] [Abstract][Full Text] [Related]
26. Alterations of p16INK4A and p15INK4B genes in gastric carcinomas.
Lee YY; Kang SH; Seo JY; Jung CW; Lee KU; Choe KJ; Kim BK; Kim NK; Koeffler HP; Bang YJ
Cancer; 1997 Nov; 80(10):1889-96. PubMed ID: 9366289
[TBL] [Abstract][Full Text] [Related]
27. Mutational analysis of the p15 and p16 genes in acute leukaemias.
Sill H; Aguiar RC; Schmidt H; Hochhaus A; Goldman JM; Cross NC
Br J Haematol; 1996 Mar; 92(3):681-3. PubMed ID: 8616035
[TBL] [Abstract][Full Text] [Related]
28. Infrequent mutations and no methylation of CDKN2A (P16/MTS1) and CDKN2B (p15/MTS2) in hepatocellular carcinoma in Taiwan.
Lin YW; Chen CH; Huang GT; Lee PH; Wang JT; Chen DS; Lu FJ; Sheu JC
Eur J Cancer; 1998 Oct; 34(11):1789-95. PubMed ID: 9893670
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of T-cell acute lymphoblastic leukemia proliferation in vivo by re-expression of the p16INK4a tumor suppressor gene.
Schoppmeyer K; Norris PS; Haas M
Neoplasia; 1999 Jun; 1(2):128-37. PubMed ID: 10933047
[TBL] [Abstract][Full Text] [Related]
30. Frequent codeletion of p16/MTS1 and p15/MTS2 and genetic alterations in p16/MTS1 in pancreatic tumors.
Naumann M; Savitskaia N; Eilert C; Schramm A; Kalthoff H; Schmiegel W
Gastroenterology; 1996 Apr; 110(4):1215-24. PubMed ID: 8613012
[TBL] [Abstract][Full Text] [Related]
31. Alterations of the p15, p16,and p18 genes in osteosarcoma.
Miller CW; Aslo A; Campbell MJ; Kawamata N; Lampkin BC; Koeffler HP
Cancer Genet Cytogenet; 1996 Feb; 86(2):136-42. PubMed ID: 8603340
[TBL] [Abstract][Full Text] [Related]
32. Primary malignant lymphoma of the brain: demonstration of frequent p16 and p15 gene deletions.
Kumanishi T; Zhang S; Ichikawa T; Endo S; Washiyama K
Jpn J Cancer Res; 1996 Jul; 87(7):691-5. PubMed ID: 8698617
[TBL] [Abstract][Full Text] [Related]
33. Codeletion of p15 and p16 genes in primary non-small cell lung carcinoma.
Xiao S; Li D; Corson JM; Vijg J; Fletcher JA
Cancer Res; 1995 Jul; 55(14):2968-71. PubMed ID: 7606711
[TBL] [Abstract][Full Text] [Related]
34. Multiple tumor-suppressor gene 1 inactivation is the most frequent genetic alteration in T-cell acute lymphoblastic leukemia.
Cayuela JM; Madani A; Sanhes L; Stern MH; Sigaux F
Blood; 1996 Mar; 87(6):2180-6. PubMed ID: 8630377
[TBL] [Abstract][Full Text] [Related]
35. Lack of mutation in the cyclin-dependent kinase inhibitor, p19INK4d, in tumor-derived cell lines and primary tumors.
Zariwala M; Xiong Y
Oncogene; 1996 Nov; 13(9):2033-8. PubMed ID: 8934552
[TBL] [Abstract][Full Text] [Related]
36. Inactivation of the p15 gene in children with acute lymphoblastic leukemia.
Cipolotti R; Lemos JA; Defavery R; Scrideli CA; Dal Fabbro AL; Tone LG
Sao Paulo Med J; 2003 Sep; 121(5):203-6. PubMed ID: 14666292
[TBL] [Abstract][Full Text] [Related]
37. Loss of chromosome arm 9p DNA and analysis of the p16 and p15 cyclin-dependent kinase inhibitor genes in human parathyroid adenomas.
Tahara H; Smith AP; Gaz RD; Arnold A
J Clin Endocrinol Metab; 1996 Oct; 81(10):3663-7. PubMed ID: 8855819
[TBL] [Abstract][Full Text] [Related]
38. A novel pre-B acute lymphoblastic leukemia cell line with chromosomal translocation between p16(INK4A)/p15(INK4B) tumor suppressor and immunoglobulin heavy chain genes: TGFbeta/IL-7 inhibitory signaling mechanism.
Urashima M; Hoshi Y; Sugimoto Y; Kaihara C; Matsuzaki M; Chauhan D; Ogata A; Teoh G; DeCaprio JA; Anderson KC
Leukemia; 1996 Oct; 10(10):1576-83. PubMed ID: 8847892
[TBL] [Abstract][Full Text] [Related]
39. Homozygous deletion of the p16/MTS1 gene in pediatric acute lymphoblastic leukemia is associated with unfavorable clinical outcome.
Kees UR; Burton PR; Lü C; Baker DL
Blood; 1997 Jun; 89(11):4161-6. PubMed ID: 9166859
[TBL] [Abstract][Full Text] [Related]
40. [Deletions and aberrant transcription of p16 and p15 genes in childhood acute lymphoblastic leukemia].
Fu G; Lu C; Zhang R
Zhonghua Xue Ye Xue Za Zhi; 1999 Jul; 20(7):366-8. PubMed ID: 11721435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
